Biologix Participates in the 2nd Saudi Rare Disease Summit, Advocating for Pediatric Neurology Awareness

Biologix participated in the 2nd Saudi Rare Disease Summit held in Riyadh, KSA, on February 16-17, 2024.

Focused on pediatric neurology, particularly CDKL5 Deficiency Disorder and Alpha Mannosidosis, the congress showed the importance of raising awareness and advancing understanding in this specialized field.

Biologix continues its commitment to advocating for improved care and support for individuals affected by rare diseases.